Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 8/2023

08.04.2023 | Original Paper

Longitudinal evaluation on negative symptoms in young people at Ultra-High Risk (UHR) of psychosis: results from a 2-year follow-up study in a real-world care setting

verfasst von: Lorenzo Pelizza, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Giuseppina Paulillo, Simona Pupo, Pietro Pellegrini, Marco Menchetti

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Negative Symptoms (NS) severely affect real-world functioning also in young people at UHR for developing psychosis. However, longitudinal research on beneficial effects of specialized treatments for NS in UHR people is still relatively scarce and inconclusive, especially in real-world care settings. The aims of the present research were: (1) to evaluate the longitudinal stability of NS levels in young UHR subjects treated within a specialized “Early Intervention in Psychosis” (EIP) program across a 2-year follow-up period, and (2) to investigate any relevant association of NS changes with the specific treatment components offered within the EIP program. One hundred UHR individuals (aged 12–25 years) completed the Positive And Negative Syndrome Scale (PANSS). A multiple linear regression analysis was conducted to examine significant associations between longitudinal changes in NS severity levels and the EIP treatment components. Across the follow-up, a significant decrease in NS clinical severity was observed. This reduction was associated with the intensity of individual psychotherapy sessions provided in the first year of treatment, a shorter duration of untreated illness at entry and the 2-year longitudinal decrease in positive symptom levels. In conclusion, NS are relevant in UHR people, but decrease over time together with the delivery of specialized EIP interventions. Specifically, our results showed that individual psychotherapy may reduce the clinical severity of NS at least during the first year of treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sauvé G, Brodeur MB, Shah JL, Lepage M (2019) The prevalence of negative symptoms across the stages of the psychosis continuum. Harv Rev Psychiatry 27:15–32PubMedCrossRef Sauvé G, Brodeur MB, Shah JL, Lepage M (2019) The prevalence of negative symptoms across the stages of the psychosis continuum. Harv Rev Psychiatry 27:15–32PubMedCrossRef
2.
Zurück zum Zitat Landi G, Leuci E, Quattrone E, Azzali S, Pellegrini C, Pellegrini P, Pelizza L (2021) The “Parma-Early Psychosis” programme: characterization of help-seekers with first episode psychosis. Early Interv Psychiatry 15:380–390PubMedCrossRef Landi G, Leuci E, Quattrone E, Azzali S, Pellegrini C, Pellegrini P, Pelizza L (2021) The “Parma-Early Psychosis” programme: characterization of help-seekers with first episode psychosis. Early Interv Psychiatry 15:380–390PubMedCrossRef
3.
Zurück zum Zitat Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH (2012) Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 196:220–224PubMedPubMedCentralCrossRef Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH (2012) Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 196:220–224PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Poletti M, Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Pupo S, Raballo A (2021) Overcoming the gap between child and adult mental health services: the Reggio Emilia experience in an early intervention in psychosis program. Early Interv Psychiatry 15:1749–1758PubMedCrossRef Poletti M, Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Pupo S, Raballo A (2021) Overcoming the gap between child and adult mental health services: the Reggio Emilia experience in an early intervention in psychosis program. Early Interv Psychiatry 15:1749–1758PubMedCrossRef
5.
Zurück zum Zitat Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, Kang JI, Lee E, Yoo SW, An SK, Kwon JS (2013) The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry 47:762–771PubMedCrossRef Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, Kang JI, Lee E, Yoo SW, An SK, Kwon JS (2013) The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry 47:762–771PubMedCrossRef
6.
Zurück zum Zitat Yung AR, Nelson B, McGorry PD, Wood SJ, Lin A (2019) Persistent negative symptoms in individuals at ultra-high risk for psychosis. Schizophr Res 206:355–361PubMedPubMedCentralCrossRef Yung AR, Nelson B, McGorry PD, Wood SJ, Lin A (2019) Persistent negative symptoms in individuals at ultra-high risk for psychosis. Schizophr Res 206:355–361PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Glenthøj LB, Kristensen TD, Wenneberg C, Hjorthøj C, Nordentoft M (2020) Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states. Schizophr Res 218:151–156PubMedCrossRef Glenthøj LB, Kristensen TD, Wenneberg C, Hjorthøj C, Nordentoft M (2020) Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states. Schizophr Res 218:151–156PubMedCrossRef
8.
Zurück zum Zitat Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P (2012) Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 38:351–359PubMedCrossRef Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P (2012) Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 38:351–359PubMedCrossRef
9.
Zurück zum Zitat Pelizza L, Garlassi S, Azzali S, Paterlini F, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2020) Anhedonia in young people with first episode psychosis: a longitudinal study. Nord J Psychiatry 74:381–389PubMedCrossRef Pelizza L, Garlassi S, Azzali S, Paterlini F, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2020) Anhedonia in young people with first episode psychosis: a longitudinal study. Nord J Psychiatry 74:381–389PubMedCrossRef
10.
Zurück zum Zitat Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2021) Negative symptom dimensions in first episode psychosis: is there a difference between schizophrenia and non-schizophrenia spectrum disorders? Early Interv Psychiatry 15:1513–1521PubMedCrossRef Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2021) Negative symptom dimensions in first episode psychosis: is there a difference between schizophrenia and non-schizophrenia spectrum disorders? Early Interv Psychiatry 15:1513–1521PubMedCrossRef
12.
Zurück zum Zitat Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M, Giordano GM, Nielsen MO, Glenthøj LB, Pezzella P, Falkai P, Dollfus S, Gaebel W (2021) EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry 64:e21PubMedPubMedCentralCrossRef Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M, Giordano GM, Nielsen MO, Glenthøj LB, Pezzella P, Falkai P, Dollfus S, Gaebel W (2021) EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry 64:e21PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2021) Anhedonia in the psychosis risk syndrome: state and trait characteristics. Psychiatr Danub 33:36–47PubMedCrossRef Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2021) Anhedonia in the psychosis risk syndrome: state and trait characteristics. Psychiatr Danub 33:36–47PubMedCrossRef
14.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRef Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRef
15.
Zurück zum Zitat Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003) Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29:703–715PubMedCrossRef Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003) Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29:703–715PubMedCrossRef
16.
Zurück zum Zitat Yung AR, Yeun HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey S, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby JA (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:64–71CrossRef Yung AR, Yeun HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey S, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby JA (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:64–71CrossRef
17.
Zurück zum Zitat Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, Kaiser S, Giordano GM, Vandevelde A, Nielsen MO, Glenthøj LB, Sabé M, Pezzella P, Bitter I, Gaebel W (2021) EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry 64:e23PubMedPubMedCentralCrossRef Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, Kaiser S, Giordano GM, Vandevelde A, Nielsen MO, Glenthøj LB, Sabé M, Pezzella P, Bitter I, Gaebel W (2021) EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry 64:e23PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Raballo A, Nelson B, Thompson A, Yung A (2011) The comprehensive assessment of at-risk mental states: from mapping the onset to mapping the structure. Schizophr Res 127:107–114PubMedCrossRef Raballo A, Nelson B, Thompson A, Yung A (2011) The comprehensive assessment of at-risk mental states: from mapping the onset to mapping the structure. Schizophr Res 127:107–114PubMedCrossRef
19.
Zurück zum Zitat Marder SR, Kirkpatrick B (2014) Defining and measuring negative symptoms of schizophrenia in clinical trials. Eur Neuropsychopharmacol 24:737–743PubMedCrossRef Marder SR, Kirkpatrick B (2014) Defining and measuring negative symptoms of schizophrenia in clinical trials. Eur Neuropsychopharmacol 24:737–743PubMedCrossRef
20.
Zurück zum Zitat Shafer A, Dazzi F (2019) Meta-analysis of the Positive and Negative Syndrome Scale (PANSS) factor structure. J Psychiatr Res 115:113–120PubMedCrossRef Shafer A, Dazzi F (2019) Meta-analysis of the Positive and Negative Syndrome Scale (PANSS) factor structure. J Psychiatr Res 115:113–120PubMedCrossRef
21.
Zurück zum Zitat Ang MS, Rekhi G, Lee J (2019) Validation of the brief negative symptom scale and its association with functioning. Schizophr Res 208:97–104PubMedCrossRef Ang MS, Rekhi G, Lee J (2019) Validation of the brief negative symptom scale and its association with functioning. Schizophr Res 208:97–104PubMedCrossRef
22.
Zurück zum Zitat Pelizza L, Maestri D, Leuci E, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: a 2-year follow-up. Early Interv Psychiatry 16:1185–1191PubMedCrossRef Pelizza L, Maestri D, Leuci E, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: a 2-year follow-up. Early Interv Psychiatry 16:1185–1191PubMedCrossRef
23.
Zurück zum Zitat Yang Z, Lim K, Lam M, Keefe R, Lee J (2018) Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra-high risk (UHR) for psychosis. Schizophr Res 201:85–90PubMedCrossRef Yang Z, Lim K, Lam M, Keefe R, Lee J (2018) Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra-high risk (UHR) for psychosis. Schizophr Res 201:85–90PubMedCrossRef
24.
Zurück zum Zitat Leuci E, Quattrone E, Pellegrini P, Pelizza L (2020) The “Parma-Early Psychosis” program: general description and process analysis after 5 years of clinical activity. Early Interv Psychiatry 14:356–364PubMedCrossRef Leuci E, Quattrone E, Pellegrini P, Pelizza L (2020) The “Parma-Early Psychosis” program: general description and process analysis after 5 years of clinical activity. Early Interv Psychiatry 14:356–364PubMedCrossRef
25.
Zurück zum Zitat Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the “Parma Early Psychosis” program. Eur Arch Psychiatry Clin Neurosci 272:621–632PubMedCrossRef Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the “Parma Early Psychosis” program. Eur Arch Psychiatry Clin Neurosci 272:621–632PubMedCrossRef
26.
Zurück zum Zitat American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders, IV edition, text revised. APA Press, Washington DC American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders, IV edition, text revised. APA Press, Washington DC
27.
Zurück zum Zitat Raballo A, Poletti M, Carpenter WT (2019) Rethinking the psychosis threshold in clinical high risk. Schizophr Bull 45:1–2PubMedCrossRef Raballo A, Poletti M, Carpenter WT (2019) Rethinking the psychosis threshold in clinical high risk. Schizophr Bull 45:1–2PubMedCrossRef
28.
Zurück zum Zitat Paterlini F, Pelizza L, Galli G, Azzali S, Scazza I, Garlassi S, Chiri LR, Poletti M, Pupo S, Raballo A (2019) Interrater reliability of the authorized Italian version of the Comprehensive Assessment of At-Risk Mental States (CAARMS-ITA). J Psychopathol 25:24–28 Paterlini F, Pelizza L, Galli G, Azzali S, Scazza I, Garlassi S, Chiri LR, Poletti M, Pupo S, Raballo A (2019) Interrater reliability of the authorized Italian version of the Comprehensive Assessment of At-Risk Mental States (CAARMS-ITA). J Psychopathol 25:24–28
29.
Zurück zum Zitat Raballo A, Semrov E, Bonner Y, Simmons MB (2013) Traduzione e adattamento italiano della CAARMS, the Comprehensive Assessment of At Risk Mental States. Regione Emilia-Romagna, Bologna Raballo A, Semrov E, Bonner Y, Simmons MB (2013) Traduzione e adattamento italiano della CAARMS, the Comprehensive Assessment of At Risk Mental States. Regione Emilia-Romagna, Bologna
30.
Zurück zum Zitat Pelizza L, Chiri LR, Azzali S, Garlassi S, Scazza I, Paterlini F, Poletti M, Pupo S, Raballo A (2021) Identifying adolescents in the early stage of psychosis: a screening checklist for referrals. J Clin Psychol 78:1184–1200PubMedCrossRef Pelizza L, Chiri LR, Azzali S, Garlassi S, Scazza I, Paterlini F, Poletti M, Pupo S, Raballo A (2021) Identifying adolescents in the early stage of psychosis: a screening checklist for referrals. J Clin Psychol 78:1184–1200PubMedCrossRef
31.
Zurück zum Zitat Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Examining disorganization in patients with first episode psychosis: findings from a 1-year follow-up of the “Parma early psychosis” program. Early Interv Psychiatry 16:552–560PubMedCrossRef Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2022) Examining disorganization in patients with first episode psychosis: findings from a 1-year follow-up of the “Parma early psychosis” program. Early Interv Psychiatry 16:552–560PubMedCrossRef
32.
Zurück zum Zitat Pancheri P, Brugnoli R, Carilli L (1995) Valutazione dimensionale della sintomatologia schizofrenica: validazione della versione italiana della Scala per la valutazione dei Sintomi Positivi e Negativi (PANNS). Ital J Psychopathol 1:60–75 Pancheri P, Brugnoli R, Carilli L (1995) Valutazione dimensionale della sintomatologia schizofrenica: validazione della versione italiana della Scala per la valutazione dei Sintomi Positivi e Negativi (PANNS). Ital J Psychopathol 1:60–75
33.
Zurück zum Zitat Cocchi A, Meneghelli A, Preti A (2008) Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis. Aust N Z J Psychiatry 42:1003–1012PubMedCrossRef Cocchi A, Meneghelli A, Preti A (2008) Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis. Aust N Z J Psychiatry 42:1003–1012PubMedCrossRef
34.
Zurück zum Zitat Pelizza L, Maestri D, Leuci E, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2021) Negative symptom configuration in patients with first episode affective psychosis: findings from the 1-year follow-up of the “Parma Early Psychosis” program. Acta Biomed 92:e2021224PubMedPubMedCentral Pelizza L, Maestri D, Leuci E, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2021) Negative symptom configuration in patients with first episode affective psychosis: findings from the 1-year follow-up of the “Parma Early Psychosis” program. Acta Biomed 92:e2021224PubMedPubMedCentral
35.
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders (SCID-I). New York State Psychiatric Institute, New York First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders (SCID-I). New York State Psychiatric Institute, New York
36.
Zurück zum Zitat Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P, Raballo A (2021) Disorganization in first episode schizophrenia: treatment response and psychopathological findings from the 2-year follow-up of the “Parma Early Psychosis” program. J Psychiatr Res 141:293–300PubMedCrossRef Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P, Raballo A (2021) Disorganization in first episode schizophrenia: treatment response and psychopathological findings from the 2-year follow-up of the “Parma Early Psychosis” program. J Psychiatr Res 141:293–300PubMedCrossRef
37.
Zurück zum Zitat Murru A, Carpiniello B (2018) Duration of untreated illness as a key to early intervention in schizophrenia: a review. Neurosci Lett 16:59–67CrossRef Murru A, Carpiniello B (2018) Duration of untreated illness as a key to early intervention in schizophrenia: a review. Neurosci Lett 16:59–67CrossRef
38.
Zurück zum Zitat Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RK, Riecher-Rössler A, van der Gaag M, Meneghelli A, Nordentoft M, Marshall M, Morrison A, Raballo A, Klosterkötter J, Ruhrmann S (2015) EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 30:388–404PubMedCrossRef Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RK, Riecher-Rössler A, van der Gaag M, Meneghelli A, Nordentoft M, Marshall M, Morrison A, Raballo A, Klosterkötter J, Ruhrmann S (2015) EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 30:388–404PubMedCrossRef
39.
Zurück zum Zitat Pelizza L, Poletti M, Azzali S, Garlassi S, Scazza I, Paterlini F, Chiri LR, Pupo S, Raballo A (2020) Subjective experience of social cognition in young people at ultra-high risk of psychosis: a 2-year longitudinal study. Nord J Psychiatry 75:97–108PubMedCrossRef Pelizza L, Poletti M, Azzali S, Garlassi S, Scazza I, Paterlini F, Chiri LR, Pupo S, Raballo A (2020) Subjective experience of social cognition in young people at ultra-high risk of psychosis: a 2-year longitudinal study. Nord J Psychiatry 75:97–108PubMedCrossRef
40.
41.
Zurück zum Zitat van der Gaag M, Nieman DH, Rietdijk J, Dragt S, Ising HK, Klaassen RMC, Koeter M, Cuijper P, Wunderink L, Linszen DH (2012) Cognitive behavioral therapy for subjects at ultra-high risk for developing psychosis: a randomized controlled trial. Schizophr Bull 38:1180–1188PubMedPubMedCentralCrossRef van der Gaag M, Nieman DH, Rietdijk J, Dragt S, Ising HK, Klaassen RMC, Koeter M, Cuijper P, Wunderink L, Linszen DH (2012) Cognitive behavioral therapy for subjects at ultra-high risk for developing psychosis: a randomized controlled trial. Schizophr Bull 38:1180–1188PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat McFarlane WR, Lynch S, Melton R (2012) Family psychoeducation in clinical high risk and first-episode psychosis. Adolesc Psychiatry 2:2012CrossRef McFarlane WR, Lynch S, Melton R (2012) Family psychoeducation in clinical high risk and first-episode psychosis. Adolesc Psychiatry 2:2012CrossRef
43.
Zurück zum Zitat Pelizza L, Ficarelli ML, Vignali E, Artoni S, Franzini MC, Montanaro S, Andreoli MV, Marangoni S, Ciampà E, Erlicher D, Troisi E, Pupo S, Fioritti A (2020) Implementation of individual placement and support in Italy: the Reggio Emilia experience. Community Ment Health J 56:1128–1138PubMedCrossRef Pelizza L, Ficarelli ML, Vignali E, Artoni S, Franzini MC, Montanaro S, Andreoli MV, Marangoni S, Ciampà E, Erlicher D, Troisi E, Pupo S, Fioritti A (2020) Implementation of individual placement and support in Italy: the Reggio Emilia experience. Community Ment Health J 56:1128–1138PubMedCrossRef
44.
Zurück zum Zitat Leuci E, Pelizza L, Landi G, Quattrone E, Maestri D, Azzali S, Pelosi A, Ceroni P, Soncini C, Daolio MC, Paulillo G, Raballo A, Pellegrini P (2022) Personal Health Budget in patients with first episode psychosis: a new rehabilitation model based on a community care system in Italy. Early Interv Psychiatry 16:221–230PubMedCrossRef Leuci E, Pelizza L, Landi G, Quattrone E, Maestri D, Azzali S, Pelosi A, Ceroni P, Soncini C, Daolio MC, Paulillo G, Raballo A, Pellegrini P (2022) Personal Health Budget in patients with first episode psychosis: a new rehabilitation model based on a community care system in Italy. Early Interv Psychiatry 16:221–230PubMedCrossRef
45.
Zurück zum Zitat SPSS Inc (2010) Statistical package for social science (SPSS) for windows, version 15.0. SPSS Inc. Press, Chicago SPSS Inc (2010) Statistical package for social science (SPSS) for windows, version 15.0. SPSS Inc. Press, Chicago
46.
Zurück zum Zitat Rosseel Y (2012) Lavaan: an R package for structural equation modelling. J Stat Softw 48:1–35CrossRef Rosseel Y (2012) Lavaan: an R package for structural equation modelling. J Stat Softw 48:1–35CrossRef
47.
Zurück zum Zitat Flora DB, Curran PJ (2004) An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods 9:466–472PubMedPubMedCentralCrossRef Flora DB, Curran PJ (2004) An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods 9:466–472PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Brown TA (2006) Confirmatory factor analysis for applied research. Guilford Press, New York, NY Brown TA (2006) Confirmatory factor analysis for applied research. Guilford Press, New York, NY
49.
Zurück zum Zitat Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6:1–55CrossRef Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6:1–55CrossRef
50.
Zurück zum Zitat Ver Hoef JM (2012) Who invented the Delta method? Am Stat 66:124–127CrossRef Ver Hoef JM (2012) Who invented the Delta method? Am Stat 66:124–127CrossRef
51.
Zurück zum Zitat Ucok A, Direk N, Kaya H, Caglar N, Cikrikcili U, Noyan H, Yokusoglu C, Devrim-Ucok M (2021) Relationship of negative symptom severity with cognitive symptom and functioning in subjects at ultra-high risk for psychosis. Early Interv Psychiatry 15:966–974PubMedCrossRef Ucok A, Direk N, Kaya H, Caglar N, Cikrikcili U, Noyan H, Yokusoglu C, Devrim-Ucok M (2021) Relationship of negative symptom severity with cognitive symptom and functioning in subjects at ultra-high risk for psychosis. Early Interv Psychiatry 15:966–974PubMedCrossRef
52.
Zurück zum Zitat Lee SJ, Kim KR, Lee SY, An SK (2017) Impaired social and role functioning in Ultra-High Risk for psychosis and first-episode schizophrenia: its relations with negative symptoms. Psychiatry Investig 14:539–545PubMedPubMedCentralCrossRef Lee SJ, Kim KR, Lee SY, An SK (2017) Impaired social and role functioning in Ultra-High Risk for psychosis and first-episode schizophrenia: its relations with negative symptoms. Psychiatry Investig 14:539–545PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2021) Longitudinal persistence of negative symptoms in young individuals with first episode schizophrenia: a 24.month multi-modal program follow-up. Nord J Psychiatry 76:530–538PubMedCrossRef Pelizza L, Leuci E, Maestri D, Quattrone E, Azzali S, Paulillo G, Pellegrini P (2021) Longitudinal persistence of negative symptoms in young individuals with first episode schizophrenia: a 24.month multi-modal program follow-up. Nord J Psychiatry 76:530–538PubMedCrossRef
54.
Zurück zum Zitat Fusar-Poli P, Sullivan SA, Shah JL, Uhlhaas PJ (2019) Improving the detection of individuals at clinical risk for psychosis in the community, primary and secondary care: an integrated evidence-based approach. Front Psychiatry 10:774PubMedPubMedCentralCrossRef Fusar-Poli P, Sullivan SA, Shah JL, Uhlhaas PJ (2019) Improving the detection of individuals at clinical risk for psychosis in the community, primary and secondary care: an integrated evidence-based approach. Front Psychiatry 10:774PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat West ML, Parrish EM, Friedman-Yakoobian M (2021) Treatment outcomes for young people at clinical high risk for psychosis: data from a specialized clinic. Early Interv Psychiatry 16:500–508PubMedCrossRef West ML, Parrish EM, Friedman-Yakoobian M (2021) Treatment outcomes for young people at clinical high risk for psychosis: data from a specialized clinic. Early Interv Psychiatry 16:500–508PubMedCrossRef
56.
Zurück zum Zitat Pozza A, Dettore D (2020) Modular cognitive-behavioral therapy for affective symptoms in young individuals at ultra-high risk of first episode of psychosis: randomized controlled trial. J Clin Psychol 76:392–405PubMedCrossRef Pozza A, Dettore D (2020) Modular cognitive-behavioral therapy for affective symptoms in young individuals at ultra-high risk of first episode of psychosis: randomized controlled trial. J Clin Psychol 76:392–405PubMedCrossRef
57.
Zurück zum Zitat Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P (2018) Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry 17:196–209PubMedPubMedCentralCrossRef Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P (2018) Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry 17:196–209PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2019) The “Reggio Emilia At-Risk Mental States” program: a diffused, “liquid” model of early intervention in psychosis implemented in an Italian Department of Mental Health. Early Interv Psychiatry 13:1513–1524PubMedCrossRef Pelizza L, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Poletti M, Pupo S, Raballo A (2019) The “Reggio Emilia At-Risk Mental States” program: a diffused, “liquid” model of early intervention in psychosis implemented in an Italian Department of Mental Health. Early Interv Psychiatry 13:1513–1524PubMedCrossRef
60.
Zurück zum Zitat Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analisis. Br J Psychiatry 205:88–94PubMedCrossRef Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analisis. Br J Psychiatry 205:88–94PubMedCrossRef
61.
Zurück zum Zitat Gupta T, Cowan HR, Strauss GP, Walker EF, Mittal VA (2021) Deconstructing negative symptoms at clinical high risk for psychosis: evidence for volitional and diminished emotionality subgroups that predict clinical presentation and functional outcome. Schizophr Bull 47:54–63PubMedCrossRef Gupta T, Cowan HR, Strauss GP, Walker EF, Mittal VA (2021) Deconstructing negative symptoms at clinical high risk for psychosis: evidence for volitional and diminished emotionality subgroups that predict clinical presentation and functional outcome. Schizophr Bull 47:54–63PubMedCrossRef
62.
Zurück zum Zitat Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The Brief Negative Symptom Scale: psychometric properties. Schizophr Bull 37:300–305PubMedCrossRef Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The Brief Negative Symptom Scale: psychometric properties. Schizophr Bull 37:300–305PubMedCrossRef
63.
Zurück zum Zitat Poletti M, Pelizza L, Azzali S, Garlassi S, Scazza I, Paterlini F, Chiri LR, Pupo S, Raballo A (2022) Subjective experience of aberrant salience in young people at Ultra-High Risk (UHR) for psychosis: a cross-sectional study. Nord J Psychiatry 76:129–137PubMedCrossRef Poletti M, Pelizza L, Azzali S, Garlassi S, Scazza I, Paterlini F, Chiri LR, Pupo S, Raballo A (2022) Subjective experience of aberrant salience in young people at Ultra-High Risk (UHR) for psychosis: a cross-sectional study. Nord J Psychiatry 76:129–137PubMedCrossRef
64.
Zurück zum Zitat Pelizza L, Poletti M, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Pupo S, Gebhardt E, Raballo A (2020) Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study. Eur Arch Psychiatry Clin Neurosci 270:337–350PubMedCrossRef Pelizza L, Poletti M, Azzali S, Paterlini F, Garlassi S, Scazza I, Chiri LR, Pupo S, Gebhardt E, Raballo A (2020) Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study. Eur Arch Psychiatry Clin Neurosci 270:337–350PubMedCrossRef
Metadaten
Titel
Longitudinal evaluation on negative symptoms in young people at Ultra-High Risk (UHR) of psychosis: results from a 2-year follow-up study in a real-world care setting
verfasst von
Lorenzo Pelizza
Emanuela Leuci
Emanuela Quattrone
Silvia Azzali
Giuseppina Paulillo
Simona Pupo
Pietro Pellegrini
Marco Menchetti
Publikationsdatum
08.04.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2023
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-023-01600-2

Weitere Artikel der Ausgabe 8/2023

European Archives of Psychiatry and Clinical Neuroscience 8/2023 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.